BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Foundation Medicine, Inc. 

One Kendall Square
Suite B3501
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-418-2200 Fax: 617-418-2201


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Foundation Medicine, Inc. (FMI) Requests Withdrawal Of $150 Million Planned Public Offering 4/18/2014 7:57:22 AM    More...
Foundation Medicine, Inc. (FMI) To Present At Upcoming Investor Conferences 2/26/2014 7:02:27 AM    More...
Foundation Medicine, Inc. (FMI) Discovers High Incidence of Clinically Actionable ERBB2 (HER2) Alterations In Aggressive Form Of Bladder Cancer; Data Published In Clinical Cancer Research 1/9/2014 8:40:30 AM    More...
Foundation Medicine, Inc. (FMI) Extends And Expands Collaboration To Provide Molecular Information And Genomic Profiling For Clinical Oncology Programs 1/7/2014 9:10:23 AM    More...
Foundation Medicine, Inc. (FMI) Release: Novel And Previously Reported Genomic Alterations Identified In Clinical Multiple Myeloma Cases Using FoundationOne™ Heme 12/10/2013 10:07:21 AM    More...
Foundation Medicine, Inc. (FMI) Release: FoundationOne™ Heme Enables Identification Of Genomic Alterations Not Identified By Conventional Methods Across Hematologic Malignancies 12/9/2013 10:13:21 AM    More...
Foundation Medicine, Inc. (FMI) Identifies Novel, Clinically Actionable Gene Fusion NTRK1 in Lung Cancer; Data Published in Nature Medicine 10/28/2013 10:46:54 AM    More...
Foundation Medicine, Inc. (FMI) Announces Publication of Analytic Validation Study of FoundationOne™ in Nature Biotechnology 10/21/2013 10:08:05 AM    More...
Foundation Medicine, Inc. (FMI) Lands $106 Million in Upsized IPO 9/25/2013 6:53:13 AM    More...
Foundation Medicine Sets Terms for $75 Million IPO 9/13/2013 10:32:35 AM    More...
123